NCT00319553View on ClinicalTrials.gov

Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®

PHASE4CompletedINTERVENTIONAL
Enrollment

647

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

December 31, 2008

Conditions
PertussisTetanusDiphtheria
Interventions
BIOLOGICAL

ADACEL®:Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed

0.5 mL, IM

BIOLOGICAL

BOOSTRIX®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed

0.5 mL, IM

Trial Locations (10)

21201

Baltimore

21401

Annapolis

21702

Frederick

27704

Durham

27705

Durham

37067

Franklin

98005

Bellevue

98075

Sammamish

98105

Seattle

98040-2758

Mercer Island

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY